DGX vs CRL — Key Metrics
| Metric | DGX (QUEST DIAGNOSTICS INC) | CRL (CHARLES RIVER LABORATORIES INTERNATIONAL INC) |
|---|---|---|
| Price | 233.07 | 295.01 |
| Market Cap | 25.72 Billion | 14.08 Billion |
| P/E (TTM) | 24.43 | -61.59 |
| P/B (Quarterly) | 3.347 | 4.383 |
| P/S (TTM) | 2.23 | 3.52 |
| Net Profit Margin (TTM) | 9.2 | -6.0 |
| Gross Margin (TTM) | 33.1 | 32.7 |
| ROE (TTM) | 14.5 | -7.7 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
DGX · QUEST DIAGNOSTICS INC
Underperform
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL INC
Greatly Underperform
Recommendation Summary
Stock DGX is projected to underperform the market, stock CRL is projected to greatly underperform the market. Upfront Recommendation: DGX.
Financial Metrics
Prices delayed ~15 min
| DGX | Metrics | CRL |
|---|---|---|
| $233.07 | Price | $295.01 |
| — | Market Capitalization | — |
| 2.23 | Price to Sales | 3.52 |
| 19.07 | Price to FCF Ratio | 38.0 |
| 6.72 | Price to Gross Profit | 10.78 |
| 9.05 | Price to Current Assets | 9.21 |